 AARP News |
COPD-asthma market to reach $47bn in 2017
PMLiVE The global market for asthma and chronic obstructive pulmonary disease (COPD) drugs is set to reach $47bn in 2017 according to a new report. US market research firm BCC Research estimates that the market for prescription drugs in these respiratory … Global Markets for Asthma, COPD Drugs to Hit $47 Billion in 2017 Meet held to discuss respiratory diseases Global Markets for Asthma & COPD Drugs to hit $47 Billion in 2017 |
View full post on asthma – Google News